-- 周一，Somnigroup International (SGI) 同意以全股票交易方式收购床上用品和家具组件制造商 Leggett & Platt (LEG)，交易价值约 25 亿美元。 两家公司在一份联合声明中表示，Leggett & Platt 的股东每持有 1 股 Leggett & Platt 股票，将获得 0.1455 股 Somnigroup 股票。合并后的公司中，Leggett & Platt 的投资者将持有约 9% 的股份。 在最近的盘前交易中，Leggett & Platt 的股价上涨了近 9%，而 Somnigroup 的股价下跌了 1.7%。 Somnigroup 首席执行官 Scott Thompson 在声明中表示：“Leggett & Platt 强大的工程能力、多元化的终端用户以及良好的现金流状况，将显著增强我们的全球平台。” Somnigroup 预计此次收购将扩大其在床上用品领域的目标市场，并使其能够进入非床上用品行业。 该交易尚需获得Leggett & Platt股东的批准以及监管机构的许可，预计将于年底前完成。交易完成后，Leggett & Platt将作为Somnigroup旗下的一个独立业务部门运营，并继续保留其位于密苏里州迦太基的办公地点。 Leggett & Platt首席执行官Karl Glassman表示：“此次交易使Leggett & Platt的股东有机会以延税方式参与这家全球领先公司的未来增长和价值创造。”交易完成后，Glassman将继续领导Leggett & Platt，并将在交易完成后的12个月内协助完成业务部门新任首席执行官的交接工作。 合并后的公司预计将在36个国家运营175家制造工厂，全球员工总数超过36,000人。 Somnigroup和Leggett & Platt预计，在交易完成后的第一年，该交易在未计入协同效应的情况下，将提升调整后每股收益。这些公司还预计，按年运行率计算，调整后息税折旧摊销前利润将增加 5000 万美元。 2 月，Leggett & Platt 公布第四季度调整后每股收益为 0.22 美元，高于上年同期的 0.21 美元。销售额同比下降 11% 至 9.386 亿美元。当时，该公司表示，预计 2026 年调整后每股收益将在 1 美元至 1.20 美元之间，销售额将在 38 亿美元至 40 亿美元之间。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB